Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study-Reference-Cited by-同舟云学术

Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study

Published:2022-11-01 Issue:1 Volume:17 Page:92-99
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Han Sungpil¹^ORCID,Choi Hee Youn²^ORCID,Kim Yo Han²^ORCID,Choi SeungChan²^ORCID,Kim Seokuee³^ORCID,Nam Ji Yeon³^ORCID,Kim Bongtae³^ORCID,Song Geun Seog³^ORCID,Lim Hyeong-Seok²^ORCID,Bae Kyun-Seop²^ORCID

Affiliation:

1. Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea

2. Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

3. Clinical Development, HK inno.N Corp., Seoul, Korea

Funder

HK inno.N Corp

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2023/017/gnl-17-1-92.pdf

Reference25 articles.

1. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease

2. Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitors

3. Are there unmet needs in acid suppression?

4. Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors

5. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

2. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

3. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

4. Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis;American Journal of Gastroenterology;2024-07-03

5. Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis;BMC Gastroenterology;2024-06-20